Biologic Therapy

PreclinicalBiologic

NNanfang Hospital, Southern Medical University

Biologic Therapy is one of 76 biologic programs targeting Inflammatory Bowel Disease. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Inflammatory Bowel DiseaseActive, not recruiting

AsthmaActive, not recruiting

Asthma; EosinophilicNot yet recruiting

Inflammatory Bowel DiseasePreclinical

Active, not recruiting

AsthmaPreclinical

Active, not recruiting

Asthma; EosinophilicPreclinical

Not yet recruiting

Competition

Competitive Landscape

175 competitors in Asthma

#DrugCompanyPhaseTrials

Celexa

AbbVie

Preclinical

1 2

Arcoxia

Novartis

Preclinical

—3

Solu-Medrol

MMassachusetts Eye and Ear Infirmary

Preclinical

1 4

DUPIXENT

Regeneron

Preclinical

1 5

Paracetamol

GSK

Preclinical

1 6

Blood Withdrawn

Emergent BioSolutions

Preclinical

1 7

Aclidinium Bromide

Atrovent

2 9

Ozone

TTanta University

Preclinical

1 10

Blood Collection

AAssistance Publique - Hôpitaux de Paris

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q4 2030

PreclinicalNot yet recruiting

Asthma; Eosinophilic

NCT07174713

Clinical

Trials by Indication[1]

Inflammatory Bowel Disease1 trial

Research on the Mechanisms of Treatment Non-response in Inflammatory Bowel Disease Based on Multi-omics Technology

Recruiting·NNanfang Hospital, Southern Medical University··NCT06447870·30 enrolled

Concentration1 trial

Study on the Correlation and Consistency of Measuring Biologic Drug Plasma Concentrations Based on Different Detection Methods

Not yet recruiting·NNanfang Hospital, Southern Medical University··NCT06849739·60 enrolled

Asthma; Eosinophilic1 trial

REverse LuNg Airway and Vascular RemOdeling in Asthma ReMission (ReNORM)

Not yet recruiting·WWestern University, Canada·Preclinical·NCT07174713·200 enrolled

Sources

References

[1]
ClinicalTrials.gov — 3 trial records for Biologic Therapy. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Biologic Therapy compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Biologic Therapy. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Nanfang Hospital, Southern Medical University company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Biologic[2]
Highest Phase: Preclinical[1]
Company: NNanfang Hospital, Southern Medical University

Biologic Therapy

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q4 2030

Trials by Indication[1]

Inflammatory Bowel Disease1 trial

Concentration1 trial

Asthma; Eosinophilic1 trial

References

Drug Info

Quick Facts

Related News